Moneycontrol PRO
Outskill Genai

business

Nectar Lifesciences hopeful of Rs 2,000 crore in FY17

Dinesh Dua, Director of Nectar Lifesciences Dinesh Dua said the company stands to gain from pharmacies destocking due to demonetisation. He expects a good Q4 show as chemists will restock supplies.

first published: Dec 16, 2016 12:53 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347